Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Dendreon Corporation    

DENDREON CORPORATION
Mes dernières consult.
Most popular
  Report  
 SummaryNewsCalendarCompanyFinancials 
Company
Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer.The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a... 
More about the company
Latest news on DENDREON CORPORATION
2015Valeant Approved to Buy Dendreon Assets for $495 Million
DJ
2015Drugmaker Valeant close to buying Salix - source
RE
2015VALEANT SECURES FINANCING FOR POTENT : Bloomberg
RE
2015Energy Future Fights for Control of its Bankruptcy -- Week Ahead
DJ
2015DENDREON : Valeant to buy Dendreon's prostate cancer vaccine Provenge
RE
2014DENDREON CORPORATION : A New Combined Approach to Cancer Immunotherapy is Needed
AC
2014DENDREON CORPORATION : Bankruptcies, Breakouts, and Busts; What's Happening in B..
AC
2014MARKET SNAPSHOT : U.S. Stocks Eke Out Monday Gains; S&P 500, Dow Hit Records
DJ
2014MARKET SNAPSHOT : U.S. Stocks Eke Out Monday Gains; S&P 500, Dow Hit Records
DJ
2014MARKET SNAPSHOT : U.S. Stocks Eke Out Monday Gains; S&P 500, Dow Hit Records
DJ
More news
Sector news : Biotechnology & Medical Research - NEC
08:59aNovartis confirms 2018 targets as Alcon recovery gains steam
RE
04/17GE rides gene therapy wave with ready-made viral drug factories
RE
04/12GSK slims portfolio with sale of rare disease gene therapy drugs
RE
04/12UK gene therapy firm Orchard plans stock offer after GSK deal
RE
04/12TAKEDA SOUNDS OUT BANKS FOR LOANS AS : sources
RE
More sector news : Biotechnology & Medical Research - NEC
Chart DENDREON CORPORATION
Duration : Period :
Dendreon Corporation Technical Analysis Chart | US24823Q1076 | 4-Traders
Income Statement Evolution
Managers
NameTitle
Craig R. Jalbert President, Secretary, Treasurer & Director
William Monteith Executive Vice President-Technical Operations
Sector and Competitors
1st jan.Capitalization (M$)
DENDREON CORPORATION0
CELLTRION, INC.--.--%33 996
IQVIA HOLDINGS INC0.92%20 419
LONZA GROUP-8.28%18 583
NEKTAR THERAPEUTICS54.96%15 041
INCYTE CORPORATION-25.70%14 904